{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:02:05Z","timestamp":1790280125439,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jval.2018.01.013","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T01:56:13Z","timestamp":1528250173000},"page":"973-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC\u00ae as Clinical Trial End Points"],"prefix":"10.1016","volume":"21","author":[{"given":"Christina","family":"Theodore-Oklota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Skrinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2018.01.013_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.jval.2018.01.013_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","article-title":"The expanding family of hypophosphatemic syndromes","volume":"30","author":"Carpenter","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jval.2018.01.013_bib3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jval.2018.01.013_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10067-010-1607-z","article-title":"Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review","volume":"30","author":"Arthur","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jval.2018.01.013_bib5","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","article-title":"Effects of therapy in X-linked hypophosphatemic rickets","volume":"325","author":"Verge","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2018.01.013_bib6","first-page":"1514","article-title":"Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets","volume":"75","author":"Rivkees","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jval.2018.01.013_bib7","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jval.2018.01.013_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-016-0538-4","article-title":"Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia","volume":"11","author":"Forestier-Zhang","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jval.2018.01.013_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jval.2018.01.013_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2018.01.013_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/2348-8093.169965","article-title":"Measuring pain in clinical trials: pain scales, endpoints, and challenges","volume":"2","author":"Bhardwaj","year":"2015","journal-title":"Int J Clin Exp Physiol"},{"key":"10.1016\/j.jval.2018.01.013_bib12","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jval.2018.01.013_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0895-4356(97)00051-6","article-title":"Measurement of morning stiffness in rheumatoid arthritis clinical trials","volume":"50","author":"Vlieland","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jval.2018.01.013_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2018.01.013_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jval.2018.01.013_bib16","unstructured":"Bellamy N. WOMAC Osteoarthritis Index User Guide Version X. Brisbane, Australia, 2012."},{"key":"10.1016\/j.jval.2018.01.013_bib17","year":"2012","journal-title":"Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)"},{"key":"10.1016\/j.jval.2018.01.013_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/DMSO.S23261","article-title":"Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan","volume":"5","author":"AlMaatouq","year":"2012","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jval.2018.01.013_bib19","first-page":"1","article-title":"Comparing pretesting methods: cognitive interviews, respondent debriefing, and behavior coding","volume":"2","author":"Hughes","year":"2004","journal-title":"Surv Methodol"},{"key":"10.1016\/j.jval.2018.01.013_bib20","series-title":"Cognitive Interviewing: A Tool for Improving Questionnaire Design","author":"Willis","year":"2004"},{"key":"10.1016\/j.jval.2018.01.013_bib21","series-title":"Qualitative Data Analysis with ATLAS.ti","author":"Friese","year":"2014"},{"key":"10.1016\/j.jval.2018.01.013_bib22","series-title":"Grounding Grounded Theory: Guidelines for Qualitative Inquiry","author":"Dey","year":"1999"},{"key":"10.1016\/j.jval.2018.01.013_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13023-015-0251-8","article-title":"Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding","volume":"10","author":"Aym\u00e9","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jval.2018.01.013_bib24","doi-asserted-by":"crossref","first-page":"A296","DOI":"10.1016\/j.jval.2016.03.2016","article-title":"Challenges and solutions associated with patient-centered outcomes in rare diseases","volume":"19","author":"Bonner","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2018.01.013_bib25","series-title":"Rare Diseases Epidemiology","first-page":"515","article-title":"Advocacy groups and their role in rare diseases research","author":"Dunkle","year":"2010"},{"key":"10.1016\/j.jval.2018.01.013_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1477-7525-8-89","article-title":"Patient reported outcomes: looking beyond the label claim","volume":"8","author":"Doward","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2018.01.013_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MLR.0b013e3182064aa2","article-title":"Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials","volume":"49","author":"Dinan","year":"2011","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2018.01.013_bib28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","article-title":"Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report","volume":"12","author":"Rothman","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2018.01.013_bib29","series-title":"Psychometric evaluation of the Brief Pain Inventory-Short Form (BPI-SF) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC\u00ae) for use in X-linked hypophosphataemia (XLH), a rare genetic disorder","author":"Theodore-Oklota","year":"2017"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301518301992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301518301992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T16:12:16Z","timestamp":1544717536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301518301992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1098301518301992"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2018.01.013","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC\u00ae as Clinical Trial End Points","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2018.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}